© 2022 MJH Life Sciences and Endocrinology Network. All rights reserved.
© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
September 20, 2022
September 19, 2022
September 17, 2022
September 16, 2022
A provider toolkit with clinically relevant resources related to diagnosis and management of central precocious puberty.
A pair of experts in the management of diabetes review the role of insulin therapy and review the approval process for biosimilars, including the FDA's approval of the first interchangeable insulin biosimilar.
Podcast hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP aimed at providing real-world perspective on the latest advances in diabetes management.
September 15, 2022
A systematic review of studies published from 1998-2021 provides insight into the potential long-term quality of life improvements achieved after undergoing parathyroidectomy in patients who primary hyperparathyroidism, with results shedding light on the quality of life changes up to 10 years after parathyroidectomy.
September 14, 2022
An analysis of data from SURPASS-2 and -3 provides evidence demonstrating the reduction in time to achieve glycemic targets and weight loss with use of tirzepatide compared with semaglutide 1.0 mg and long-acting insulin degludec.
An analysis of data from more than 100,000 hospitalizations for hypoglycemia and hyperglycemic emergencies provides insight into the purported increase in risk for these events observed with extreme heat.
September 13, 2022
Released on September 13, the US Preventive Services Task Force concluded there was a lack of sufficient evidence related to the benefits and harms of screening in their first-ever recommendation statement on screening for type 2 diabetes and prediabetes in children with no known history or symptoms of either disease.
September 12, 2022
A study presented at ASBMR 2022 leveraging data from more than a dozen countries details trends in hip fracture incidence and projects potential incidence increases by 2050.